Geopolitical crises are taking a toll on stocks as we head into the seasonally weak month of August.
VIDEO ON MSN MONEY
Here's a look at a leader in HIV/AIDS treatments and a pioneering play in molecular diagnosis.
Cepheid (CPHD) has a very large idea -- it's aiming to "democratize" molecular diagnostic testing through its revolutionary GeneXpert system.
Gilead Sciences (GILD) is a big biopharmaceutical company with 14 products on the market, including ﬁve medicines for the treatment of HIV/AIDS that accounted for 86% of 2010 revenue.
These small caps that focus on specific software niches have been sporting good price appreciation lately.
By Kate Stalter, MoneyShow.com
Although there was much media fanfare Monday as Apple (AAPL) reached $500, small caps are outpacing their larger cousins' price growth so far in 2012.
The cloud-based business software has been in the spotlight recently, with small caps clearly setting the pace for gains.
After Wednesday's drop, the stock rebounds to make a small afternoon gain.
Apple (AAPL) went back to its pattern of climbing ever higher Thursday, comforting investors who had been watching for a repeat of Wednesday's drop.
After a morning of fingernail biting, Apple shares moved into positive territory in the afternoon and closed at $502.21 -- nearly 1% above Wednesday's $497.67 close.
The day was not an easy one for some investors. "AAPL is giving me an ULCR," one wrote on Twitter.
Ralph Lauren is upgraded to 'buy,' while Deere is downgraded to 'market perform.'
Thursday's noteworthy upgrades include:
The Tiffany network needs to account for its aging viewers and the overall changes in people's media habits.
CBS' (CBS) advertising revenue declined in the fourth quarter and in 2011 despite the network's being home to some of the best and most popular shows on television, including "Big Bang Theory," "Two Broke Girls" and "Person of Interest." How sad is that?
The Tiffany network cited the usual suspects, including lower political advertising sales and lost revenue from the NBA lockout. Advertising revenue fell to $2.51 billion from $2.62 billion in the fourth quarter and to $9 billion from $9.15 billion last year. Fourth-quarter revenue figures missed Wall Street estimates. Net income, however, rose 31% as rising license revenue and cost cutting offset the slowdown in advertising.
CBS needs to address the fact that the network TV audience is shrinking and getting older.
The momentum hounds who bought the stock on its 9-day climb were scared by its last-minute tumble Wednesday, but they need to realize it can rise again soon.
We all saw it, the hideous, horrible reversal in Apple (AAPL) stock Wednesday and the plummet into the close. It transfixed us. Reversed hard. An intraday reversal. The kind of reversal that any rookie chartist would tell you is the beginning of a rollover. The kind of reversal that, immediately, signaled to everyone I know that the run in Apple -- and the stock market, for that matter -- is over. No questions asked. Done. Finished.
Now because of that rollover there are people, for the first time in nine days, who are down on the stock. They have losses. They chased. They top-ticked for the moment, and now they are furious and they are scared and they are looking over their shoulders and of course they are blaming me.
Any business would kill for this problem: a savings account so flush it's making investors antsy.
New CEO Tim Cook hinted as much Tuesday in his address to the Goldman Sachs Technology and Internet Conference. "I'd be the first to admit, we have more cash than we need to run the businesss," said the famously frugal Cook. But Apple will continue to spend its money judiciously, he added. "We are not going to run out and have a toga party."
The global economy looks shaky, but these dividends are sturdy.
In case you hadn't noticed, it's rough out there. Europe still is quite the mess. China, while still growing, is looking a little suspect these days, and growth in much of the rest of the developing world -- particularly in commodity-exporting countries like Brazil -- depends on Chinese growth that might not materialize if present trends continue.
If you're depending purely on growth to meet your investment goals, you might end up being sorely disappointed. Prudent investors instead should turn to something a little more reliable: income.
To overcome patent expirations, Bristol-Myers Squibb is pursing acquisitions.
To overcome patent expirations, the drug firm is actively pursing acquisitions to strengthen its drug pipeline.
Last month, Bristol-Myers Squibb (BMY) announced that it will buy biotech company Inhibitex for $2.5 billion. The deal will give the pharmaceutical giant a beachhead in the rapidly growing market for hepatitis C virus (HCV) treatments, once regulatory and shareholder approvals are received later this year.
But the automaker misses forecasts because of global troubles, and the record earnings may not thrill the still-struggling people of a nation that bailed the company out.
General Motors (GM) earned its highest profit ever last year, a staggering $7.6 billion on revenue of more than $105 billion.
Yay for GM, right? Well, not really.
Unfortunately, Wall Street was already expecting dramatic profits -- and the automaker actually fell short. What's more, sales overseas were very ugly, including at European and South American operations that were in the red. And let's not forget the outrage some taxpayers are feeling after a money-losing bailout of the Detroit automaker that has helped it rake in record profits.
It all adds up to a very sticky situation for this "successful" automaker in 2012.
A trade deal with China offers another reason for investors to take a good look at Canadian equities.
Canadian Prime Minister Stephen Harper didn't just have close encounters with panda bears during his recent official trip to China. He spent a lot of time cozying up to top officials and businessmen and scored a big agreement: Going forward, Canadian companies will be given the same treatment as domestic Chinese enterprises when they do business there.
The agreement comes hard on the heels of tough comments by Harper that ensuring "market security" might mean Canada ramps up its efforts to sell energy products to trading partners other than the U.S. And China is a willing buyer, Chinese Premier Wen Jiabao told Harper during the trip.
The automaker receives $40 million in advance orders just one day after announcing its newest vehicle.
A day after the company revealed the car, it said it received more than $40 million in advance orders. You only need to put down $5,000 to reserve one -- and that amount is fully refundable -- but it does show legitimate enthusiasm for a car that won't be delivered until 2014.
Tesla hasn't even said how much the sports-utility vehicle will cost.
The Andersons reported a great 2011. Problem is, few expect it to repeat the record performance.
By Tracey Ryniec
The Andersons (ANDE) had a record 2011 as the agriculture sector remained hot. Still, the stock gets no love from investors, and has a forward price-to-earnings ratio of just 9.4.
The Andersons (yes, that's really the company's name) was founded in 1947 by Harold Anderson in Ohio. Originally a single-grain elevator and truck terminal, it has grown into an agribusiness company with five business segments in 16 states and Puerto Rico. It also has rail-equipment leasing interests in Canada and Mexico.
The cable company's fourth-quarter earnings see a surprising jump.
Comcast (CMCSA) said Wednesday that fourth-quarter profits shot up 26%, largely due to growth in its broadband and business-services divisions. The cable provider also said that it had curbed defections of pay-TV subscribers for the fifth quarter in a row.
The company announced a 44% dividend increase and a $6.5 billion share buyback program.
The numbers make for fascinating reading.
The stock takes a post-earnings fall as questions arise about sales and incremental margins.
MORE ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Investors are anxious to see if hiring can maintain its strong pace in the second half of the year.
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
[BRIEFING.COM] The stock market punctuated July with a broad-based retreat that sent the S&P 500 lower by 2.0% with all ten sectors ending in the red. The benchmark index posted a monthly decline of 1.5%, while the Russell 2000 (-2.3%) underperformed to end the month lower by 6.1%.
To get a better feel for what led to today's retreat, we'd like to look back to Wednesday, when the market had ample reason to rally, but did not. Instead, it ended basically flat after a sloppy day of ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|